Valuation: Akums Drugs and Pharmaceuticals Limited

Market Cap 112B 1.19B 1.06B 971M 884M 1.66B 1.69B 11.6B 4.68B 59.25B 4.45B 4.36B 187B P/E 2027 *
26.8x
P/E 2028 * 21.2x
Enterprise Value 112B 1.19B 1.06B 971M 884M 1.66B 1.69B 11.6B 4.68B 59.25B 4.45B 4.36B 187B EV / Sales 2027 *
2.23x
EV / Sales 2028 * 1.94x
Free-Float
14.66%
Yield 2027 *
-
Yield 2028 * -
1 day+0.20%
1 week+9.59%
Current month+0.20%
1 month-9.83%
3 months+11.36%
6 months+33.96%
Current year+61.70%
1 week 676
Extreme 676
755
1 month 658
Extreme 658
833
Current year 409.3
Extreme 409.3
838.8
1 year 409.3
Extreme 409.3
838.8
3 years 405
Extreme 405
1,175.9
5 years 405
Extreme 405
1,175.9
10 years 405
Extreme 405
1,175.9
Manager TitleAgeSince
Chief Executive Officer 59 2004-12-18
Chief Executive Officer 60 2004-12-18
Director of Finance/CFO - 2022-02-13
Director TitleAgeSince
Director/Board Member 74 2022-03-15
Director/Board Member 62 2024-01-16
Director/Board Member 60 2004-12-18
Change 5-day change 1-year change 3-year change Capi.($)
+0.20%+9.59%+59.12% - 1.18B
-0.68%+9.99%+56.92%+142.44% 1,263B
-1.30%+1.06%+44.49%+79.13% 658B
-2.22%+0.39%+35.81%+100.93% 521B
-1.54%+0.18%+53.06%+66.79% 391B
-0.41%+5.83%+80.40%+44.69% 369B
-1.69%+3.17%+32.18%+55.35% 307B
-0.72%+7.83%+12.10%+33.76% 290B
+0.24%+4.91%+57.43%+74.97% 252B
-0.01%+7.32%+39.54%+109.66% 212B
Average -0.86%+5.50%+47.10%+78.64% 426.31B
Weighted average by Cap. -1.05%+6.60%+48.44%+92.91%

Financials

2027 *2028 *
Net sales 50.25B 531M 474M 435M 396M 742M 756M 5.19B 2.09B 26.52B 1.99B 1.95B 83.77B 57.8B 611M 545M 500M 455M 853M 870M 5.97B 2.41B 30.51B 2.29B 2.24B 96.37B
Net income 4.24B 44.8M 40M 36.71M 33.39M 62.6M 63.85M 438M 177M 2.24B 168M 165M 7.07B 5.37B 56.74M 50.66M 46.48M 42.29M 79.28M 80.86M 555M 224M 2.84B 213M 208M 8.95B
Net Debt - -
Projected Income Statement - Annual - Akums Drugs and Pharmaceuticals Limited
Logo Akums Drugs and Pharmaceuticals Limited
Akums Drugs and Pharmaceuticals Limited is an India-based pharmaceutical contract development and manufacturing company. The Company is engaged in the business of manufacturing, marketing, trading, importing, exporting, developing, testing and allied activities of pharmaceutical formulations of drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over the counter (OTC) products, active pharmaceutical ingredients, excipients and compounds. Its segments include Contract Development and Manufacturing Operations (CDMO), International Branded Formulations, Domestic Branded Formulations, Active Pharmaceutical Ingredients (API) and Trade Generics. CDMO is engaged in formulation research and development, preparation and regulatory filing of dossiers, manufacturing formulations on contract basis, job work and testing services. API is engaged in the manufacture and sale of KSM, Intermediate and API products.
Employees
7,337
Date Price Change Volume
26-11-01 ₹733.15 +0.20% 99,789
26-10-30 ₹731.70 -1.26% 145,381
26-10-29 ₹741.05 +2.54% 110,472
26-10-28 ₹722.70 +0.48% 77,503
26-10-27 ₹719.25 +4.76% 141,850
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Akums Drugs and Pharmaceuticals Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
733.15INR
Average target price
863.33INR
Spread / Average Target
+17.76%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Akums Drugs and Pharmaceuticals Limited
  1. Stock Market
  2. Stocks
  3. AKUMS Stock